19 May 2013
Keywords: fillip, biogen, fda, sets, new, trial, requirement
Article | 24 June 2002
Biogen moved a step closer towards US approval of its new treatment formoderate-to-severe chronic plaque psoriasis, Amevive (alefacept), with
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 June 2002
1 July 2002
17 May 2013
© 2013 thepharmaletter.com